RxDoctor Payments Data

Mikayla Andrea

Primary Care · Phoenix, AZNPI 1346971629

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $632 and has fallen 78.0% since, to $139 in 2025.

$1,104in general payments, 2019–2025

Across 36 payments — averaging $30.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BD$260
  • Myriad Women's Health, Inc.$122
  • Gynesonics, Inc.$118
  • Mayne Pharma Commercial LLC$93
  • Novo Nordisk$83
  • Organon$73
  • plus $355 from 13 others

What the payments were for

  • Food & beverage$1,09099%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,104 in reported general payments places this provider in the 70th percentile of 151 primary care providers in Arizona.

See all primary care providers in Arizona

Medicare billing

Part B allowed, 2024
$13,727
Medicare patients
81
Services billed
190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol153$9,536
ProgesteroneProgesterone, Micronized46$1,815
Estradiol (Twice Weekly)Estradiol19$1,337
Clobetasol Propionate32$1,181
XulaneNorelgestromin/Ethin.Estradiol12$1,054
Estradiol (Once Weekly)Estradiol12$740
Medroxyprogesterone Acetate13$267

Paid to pharmacies, not to this prescriber.

Other primary care in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →